Shalini Sharp - 22 May 2024 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Reporting relationship
Director
Issuer ticker
NBIX
Reported as of
22 May 2024
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
23 May 2024, 18:34:03 UTC
Prior SEC filing
21 May 2024
Next SEC filing
11 Jun 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Darin Lippoldt, Attorney-in-Fact

Key filing fact

Shalini Sharp filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX) on 23 May 2024.

Key facts

  • This page summarizes Shalini Sharp's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
  • 2 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 23 May 2024, 18:34.

Change

  • Previous filing in this sequence was filed on 21 May 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NBIX transaction Derivative

Restricted Stock Unit

Award

Transaction value
$0
Shares
+1,435
Change %
Price
$0.000000
Shares after
1,435
Date
22 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,435
Exercise price
$0.000000
Footnotes
F1, F2
NBIX transaction Derivative

Non-Qualified Stock Option

Award

Transaction value
$0
Shares
+2,982
Change %
Price
$0.000000
Shares after
2,982
Date
22 May 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,982
Exercise price
$139.43
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

Footnote F2

The RSUs will vest in full on May 22, 2025.

Footnote F3

Option vests in 12 monthly installments beginning June 22, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .